{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:30:57Z","timestamp":1771662657284,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10528-023-10443-4","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:08:56Z","timestamp":1688958536000},"page":"741-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and Validation of a Prognostic Risk Prediction Model for Lactate Metabolism-Related lncRNA in Endometrial Cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Fenghua","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"10443_CR1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60583","author":"T Ali","year":"2020","unstructured":"Ali T, Grote P (2020) Beyond the RNA-dependent function of LncRNA genes. Elife. https:\/\/doi.org\/10.7554\/eLife.60583","journal-title":"Elife"},{"issue":"15","key":"10443_CR2","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77(15):3965\u20133981. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2634","journal-title":"Cancer Res"},{"key":"10443_CR3","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202009045","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202009045","journal-title":"J Cell Biol"},{"issue":"1","key":"10443_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-021-00301-z","volume":"9","author":"W Cao","year":"2021","unstructured":"Cao W, Ma X, Fischer JV, Sun C, Kong B, Zhang Q (2021) Immunotherapy in endometrial cancer: rationale, practice and perspectives. Biomark Res 9(1):49. https:\/\/doi.org\/10.1186\/s40364-021-00301-z","journal-title":"Biomark Res"},{"issue":"8","key":"10443_CR5","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.7150\/thno.41427","volume":"10","author":"J Chu","year":"2020","unstructured":"Chu J, Niu X, Chang J, Shao M, Peng L, Xi Y, Lin A, Wang C, Cui Q, Luo Y, Fan W, Chen Y, Sun Y, Guo W, Tan W, Lin D, Wu C (2020) Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma. Theranostics 10(8):3488\u20133502. https:\/\/doi.org\/10.7150\/thno.41427","journal-title":"Theranostics"},{"key":"10443_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science. https:\/\/doi.org\/10.1126\/science.aaw5473","journal-title":"Science"},{"issue":"1","key":"10443_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/bib\/bbv031","volume":"17","author":"F Ferre","year":"2016","unstructured":"Ferre F, Colantoni A, Helmer-Citterich M (2016) Revealing protein-lncRNA interaction. Brief Bioinform 17(1):106\u2013116. https:\/\/doi.org\/10.1093\/bib\/bbv031","journal-title":"Brief Bioinform"},{"issue":"3","key":"10443_CR8","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.3802\/jgo.2022.33.e47","volume":"33","author":"A Goulder","year":"2022","unstructured":"Goulder A, Gaillard SL (2022) Molecular classification of endometrial cancer: entering an era of precision medicine. J Gynecol Oncol 33(3):e47. https:\/\/doi.org\/10.3802\/jgo.2022.33.e47","journal-title":"J Gynecol Oncol"},{"key":"10443_CR9","doi-asserted-by":"publisher","first-page":"955979","DOI":"10.3389\/fonc.2022.955979","volume":"12","author":"C Gu","year":"2022","unstructured":"Gu C, Lin C, Zhu Z, Hu L, Wang F, Wang X, Ruan J, Zhao X, Huang S (2022a) The IFN-gamma-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma. Front Oncol 12:955979. https:\/\/doi.org\/10.3389\/fonc.2022.955979","journal-title":"Front Oncol"},{"key":"10443_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091722","author":"I Gu","year":"2022","unstructured":"Gu I, Gregory E, Atwood C, Lee SO, Song YH (2022b) Exploring the role of metabolites in cancer and the associated nerve crosstalk. Nutrients. https:\/\/doi.org\/10.3390\/nu14091722","journal-title":"Nutrients"},{"issue":"12","key":"10443_CR11","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M (2022) Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell 82(12):2252\u20132266. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.027","journal-title":"Mol Cell"},{"issue":"22","key":"10443_CR12","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UG, Mueller-Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71(22):6921\u20136925. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1457","journal-title":"Cancer Res"},{"key":"10443_CR13","doi-asserted-by":"publisher","first-page":"689992","DOI":"10.3389\/fcell.2021.689992","volume":"9","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Azimi T, Abak A, Hidayat HJ, Taheri M, Ghafouri-Fard S (2021) Role of lncRNA BANCR in human cancers: an updated review. Front Cell Dev Biol 9:689992. https:\/\/doi.org\/10.3389\/fcell.2021.689992","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10443_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/jog.13867","volume":"45","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Banno K, Kunitomi H, Takahashi T, Takeda T, Nakamura K, Tsuji K, Tominaga E, Aoki D (2019) Warburg effect in gynecologic cancers. J Obstet Gynaecol Res 45(3):542\u2013548. https:\/\/doi.org\/10.1111\/jog.13867","journal-title":"J Obstet Gynaecol Res"},{"key":"10443_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176073","author":"S Kyo","year":"2020","unstructured":"Kyo S, Nakayama K (2020) Endometrial cancer as a metabolic disease with dysregulated PI3K signaling: shedding light on novel therapeutic strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176073","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10443_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H (2016) Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci 73(2):377\u2013392. https:\/\/doi.org\/10.1007\/s00018-015-2070-4","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10443_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12079-021-00651-1","volume":"16","author":"H Liu","year":"2022","unstructured":"Liu H, Wan J, Feng Q, Li J, Liu J, Cui S (2022) Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway. J Cell Commun Signal 16(2):253\u2013270. https:\/\/doi.org\/10.1007\/s12079-021-00651-1","journal-title":"J Cell Commun Signal"},{"key":"10443_CR18","doi-asserted-by":"publisher","first-page":"829175","DOI":"10.3389\/fendo.2022.829175","volume":"13","author":"S Mai","year":"2022","unstructured":"Mai S, Liang L, Mai G, Liu X, Diao D, Cai R, Liu L (2022) Development and validation of lactate metabolism-related lncRNA signature as a prognostic model for lung adenocarcinoma. Front Endocrinol (lausanne) 13:829175. https:\/\/doi.org\/10.3389\/fendo.2022.829175","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1","key":"10443_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, Oaknin A (2021) Endometrial cancer. Nat Rev Dis Primers 7(1):88. https:\/\/doi.org\/10.1038\/s41572-021-00324-8","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"10443_CR20","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1158\/1078-0432.CCR-21-1564","volume":"28","author":"JA Marin-Jimenez","year":"2022","unstructured":"Marin-Jimenez JA, Garcia-Mulero S, Matias-Guiu X, Piulats JM (2022) Facts and hopes in immunotherapy of endometrial cancer. Clin Cancer Res 28(22):4849\u20134860. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1564","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10443_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ygyno.2019.08.001","volume":"154","author":"JN McAlpine","year":"2019","unstructured":"McAlpine JN, Gilks CB (2019) Precision medicine in endometrial cancer. Gynecol Oncol 154(3):451\u2013453. https:\/\/doi.org\/10.1016\/j.ygyno.2019.08.001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10443_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ogc.2018.09.006","volume":"46","author":"ME McDonald","year":"2019","unstructured":"McDonald ME, Bender DP (2019) Endometrial cancer: obesity, genetics, and targeted agents. Obstet Gynecol Clin North Am 46(1):89\u2013105. https:\/\/doi.org\/10.1016\/j.ogc.2018.09.006","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"10443_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10585-021-10102-1","volume":"38","author":"JA Mosier","year":"2021","unstructured":"Mosier JA, Schwager SC, Boyajian DA, Reinhart-King CA (2021) Cancer cell metabolic plasticity in migration and metastasis. Clin Exp Metastasis 38(4):343\u2013359. https:\/\/doi.org\/10.1007\/s10585-021-10102-1","journal-title":"Clin Exp Metastasis"},{"issue":"35","key":"10443_CR24","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1200\/jco.2016.69.4638","volume":"34","author":"MA Onstad","year":"2016","unstructured":"Onstad MA, Schmandt RE, Lu KH (2016) Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol 34(35):4225\u20134230. https:\/\/doi.org\/10.1200\/jco.2016.69.4638","journal-title":"J Clin Oncol"},{"key":"10443_CR25","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.drup.2022.100822","volume":"61","author":"M Pi","year":"2022","unstructured":"Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang DH, Wu S (2022) Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resist Updat 61:100822. https:\/\/doi.org\/10.1016\/j.drup.2022.100822","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10443_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.ygyno.2021.03.020","volume":"161","author":"N Rahimian","year":"2021","unstructured":"Rahimian N, Razavi ZS, Aslanbeigi F, Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR, Mirzaei H (2021) Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol 161(3):896\u2013912. https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.020","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10443_CR27","doi-asserted-by":"publisher","first-page":"26463","DOI":"10.3390\/ijms161125962","volume":"16","author":"MA Smolle","year":"2015","unstructured":"Smolle MA, Bullock MD, Ling H, Pichler M, Haybaeck J (2015) Long non-coding RNAs in endometrial carcinoma. Int J Mol Sci 16(11):26463\u201326472. https:\/\/doi.org\/10.3390\/ijms161125962","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10443_CR28","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1158\/1078-0432.CCR-18-0412","volume":"24","author":"TE Soumerai","year":"2018","unstructured":"Soumerai TE, Donoghue MTA, Bandlamudi C, Srinivasan P, Chang MT, Zamarin D, Cadoo KA, Grisham RN, O\u2019Cearbhaill RE, Tew WP, Konner JA, Hensley ML, Makker V, Sabbatini P, Spriggs DR, Troso-Sandoval TA, Charen AS, Friedman C, Gorsky M et al (2018) Clinical utility of prospective molecular characterization in advanced endometrial cancer. Clin Cancer Res 24(23):5939\u20135947. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0412","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10443_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tig.2015.03.007","volume":"31","author":"G St Laurent","year":"2015","unstructured":"St Laurent G, Wahlestedt C, Kapranov P (2015) The Landscape of long noncoding RNA classification. Trends Genet 31(5):239\u2013251. https:\/\/doi.org\/10.1016\/j.tig.2015.03.007","journal-title":"Trends Genet"},{"issue":"12","key":"10443_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P (2022) Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 13(12):877\u2013919. https:\/\/doi.org\/10.1007\/s13238-021-00846-7","journal-title":"Protein Cell"},{"issue":"2","key":"10443_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (lond) 41(2):109\u2013120. https:\/\/doi.org\/10.1002\/cac2.12108","journal-title":"Cancer Commun (lond)"},{"issue":"2","key":"10443_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1021\/acs.jproteome.7b00503","volume":"17","author":"J Troisi","year":"2018","unstructured":"Troisi J, Sarno L, Landolfi A, Scala G, Martinelli P, Venturella R, Di Cello A, Zullo F, Guida M (2018) Metabolomic signature of endometrial cancer. J Proteome Res 17(2):804\u2013812. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00503","journal-title":"J Proteome Res"},{"issue":"9","key":"10443_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","volume":"19","author":"ME Urick","year":"2019","unstructured":"Urick ME, Bell DW (2019) Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer 19(9):510\u2013521. https:\/\/doi.org\/10.1038\/s41568-019-0177-x","journal-title":"Nat Rev Cancer"},{"issue":"5930","key":"10443_CR34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science"},{"issue":"6","key":"10443_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1373\/clinchem.2017.285981","volume":"64","author":"A Waalkes","year":"2018","unstructured":"Waalkes A, Smith N, Penewit K, Hempelmann J, Konnick EQ, Hause RJ, Pritchard CC, Salipante SJ (2018) Accurate pan-cancer molecular diagnosis of microsatellite instability by single-molecule molecular inversion probe capture and high-throughput sequencing. Clin Chem 64(6):950\u2013958. https:\/\/doi.org\/10.1373\/clinchem.2017.285981","journal-title":"Clin Chem"},{"key":"10443_CR36","doi-asserted-by":"publisher","first-page":"111158","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"C Xing","year":"2021","unstructured":"Xing C, Sun SG, Yue ZQ, Bai F (2021) Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother 134:111158. https:\/\/doi.org\/10.1016\/j.biopha.2020.111158","journal-title":"Biomed Pharmacother"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10443-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T08:12:17Z","timestamp":1713514337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10443-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10443"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10443-4","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Medical Ethics Committee of the Third Affiliated Hospital of Zhengzhou University, and informed consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}